News

Stay up to date with Addition!

  • Press Releases
  • In the News

Press Releases

April 27, 2026

Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Read More

December 17, 2025

Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases

Read More

In the News

Endpoints | April 24, 2026

Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy

Article behind paywall

Read More
BioCentury | December 17, 2025

Addition Therapeutics: One genomic safe site, many DNA insertions

Article behind paywall

Read More
BioPharma Dive | December 17, 2025

Addition emerges with $100M to make gene therapies for chronic and rare diseases

Read More
BioSpace | December 17, 2025

Addition debuts with $100M to advance one-time therapies for rare, chronic diseases

Read More
BioWorld Today | December 17, 2025

Addition launches with an all-RNA, lipid nanoparticle-based gene therapy

Read More
Endpoints | December 17, 2025

Berkeley startup raises $106.5M for all RNA ‘jumping gene’ therapies

Read More
FierceBiotech | December 17, 2025

Addition Tx does the math and emerges from stealth with $100M, biotech vets on exec team

Read More
FirstWord Pharma | December 17, 2025

Addition launches with $100M to advance non-viral gene therapy platform

Read More
San Francisco Business Journals | December 17, 2025

UC Berkeley spinout raises $100 million for gene-therapy approach that ‘unlocks a world of possibility’

Article behind paywall

Read More